Earnings Call Insights: Bio-Rad Laboratories, Inc. (BIO) Q2 2025 Norman Schwartz, Chairman & CEO, indicated Bio-Rad delivered solid execution in Q2 2025, with both revenue and operating margin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback